Arax Advisory Partners’s Masco MAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.68M Buy
20,666
+19,111
+1,229% +$1.33M 0.01% 929
2026
Q1
$93.9K Sell
1,555
-4,104
-73% -$278K ﹤0.01% 1418
2025
Q4
$329K Sell
5,659
-22,478
-80% -$1.46M 0.01% 783
2025
Q3
$1.98M Buy
28,137
+27,233
+3,013% +$1.92M 0.03% 467
2025
Q2
$69.2K Buy
904
+337
+59% +$21.2K ﹤0.01% 1095
2025
Q1
$39.4K Sell
567
-207
-27% -$15.5K ﹤0.01% 1043
2024
Q4
$56.2K Buy
774
+330
+74% +$26.4K ﹤0.01% 870
2024
Q3
$37.3K Buy
444
+122
+38% +$9.25K ﹤0.01% 825
2024
Q2
$21.5K Buy
+322
New +$22.7K ﹤0.01% 942
2023
Q3
Sell
-104
Closed -$5.97K 1352
2023
Q2
$5.97K Buy
104
+95
+1,056% +$4.97K ﹤0.01% 825
2023
Q1
$448 Sell
9
-3
-25% -$155 ﹤0.01% 1206
2022
Q4
$560 Hold
12
﹤0.01% 1167
2022
Q3
$1K Hold
12
﹤0.01% 1108
2022
Q2
$1K Buy
+12
New +$635 ﹤0.01% 1070
2018
Q2
Sell
-46
Closed -$1K 493
2018
Q1
$1K Buy
+46
New +$1.98K ﹤0.01% 458

Other funds holding MAS

Arax Advisory Partners's MAS Position: Q2 2026 in Review

Arax Advisory Partners increased its Masco (MAS) stake by 1,229% in Q2 2026, buying an estimated $1.33M and bringing the position to 20,666 shares worth $1.68M. The position accounts for 0.01% of the portfolio, ranked #929.

Arax Advisory Partners first reported a position in MAS in Q1 2018 and has held it in 15 quarters since. The position peaked at $1.98M in Q3 2025. 915 funds tracked by Wall St. Rank hold MAS as of Q2 2026.

  • Arax Advisory Partners held 20,666 shares of Masco worth $1.68M as of Q2 2026.
  • Arax Advisory Partners bought 19,111 Masco shares in Q2 2026, an estimated $1.33M.
  • Masco made up 0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #929 holding.
  • Arax Advisory Partners first reported a position in Masco in Q1 2018 and has held it in 15 quarters since.
  • Arax Advisory Partners's Masco position peaked at $1.98M in Q3 2025.
  • 915 funds tracked by Wall St. Rank held Masco as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.